Academic · Private company
Sarcoma Alliance for Research through Collaboration
Track this companyFree. Adds Sarcoma Alliance for Research through Collaboration to your Dealase workspace and tells you when its record changes.
Clinical trials96 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials9
- SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid HemangioendotheliomaPHASE2 · RECRUITING · started Feb 24, 2026ClinicalTrials.gov NCT07104331 · fetched Nov 12, 2026
- A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaPHASE2 · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT06942442 · fetched Nov 12, 2026
- SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GISTPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 1, 2024ClinicalTrials.gov NCT06208748 · fetched Nov 12, 2026
- SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated LiposarcomaPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 11, 2021ClinicalTrials.gov NCT04967521 · fetched Nov 12, 2026
- SARC038: Phase 2 Study of Regorafenib and Nivolumab in OsteosarcomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 4, 2021ClinicalTrials.gov NCT04803877 · fetched Nov 12, 2026
- SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma PatientsPHASE1_PHASE2 · COMPLETED · started Jan 5, 2021ClinicalTrials.gov NCT04067115 · fetched Nov 12, 2026
- SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath TumorsPHASE2 · COMPLETED · started Oct 2, 2019ClinicalTrials.gov NCT03433183 · fetched Nov 12, 2026
- A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the ExtremityPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 19, 2017ClinicalTrials.gov NCT03092323 · fetched Nov 12, 2026
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma SubtypesPHASE2 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02048371 · fetched Nov 12, 2026